Elevated baseline D-dimer levels were independently associated with an increased risk of PSE within one year after AIS, and as a routinely available biomarker, D-dimer may inform risk assessment in acute stroke units.
Abstract
Background
Post-stroke epilepsy (PSE) is a severe complication following acute ischemic stroke (AIS), yet early identification of patients at high risk remains challenging. This study evaluated the association between baseline D-dimer levels and incident PSE within one year after AIS.
Methods
In this secondary analysis of a multicenter retrospective cohort, 21,459 patients with first-ever AIS were included. D-dimer was modeled as a log2-transformed continuous variable. Multivariable logistic regression with progressive adjustment, restricted cubic spline analysis, and sensitivity analyses were performed. Internal validation was conducted using bootstrap resampling.
Results
The median baseline D-dimer level was 0.92 mg/L (IQR 0.65-1.49). PSE occurred in 936 patients (4.36%). After full adjustment, each doubling of D-dimer was associated with a 3.3-fold increase in PSE odds (OR 3.33, 95% CI 2.94-3.78). The association remained consistent in sensitivity analyses excluding patients with deep vein thrombosis (OR 3.86, 95% CI 3.37-4.43), atrial fibrillation (OR 3.50, 95% CI 3.04-4.04), or extreme D-dimer values (OR 3.41, 95% CI 2.99-3.91). A non-linear relationship was observed, with PSE risk rising more steeply at higher D-dimer levels. The C-statistic for the fully adjusted model was 0.968.
Conclusion
Elevated baseline D-dimer levels were independently associated with an increased risk of PSE within one year after AIS. As a routinely available biomarker, D-dimer may inform risk assessment in acute stroke units; however, external validation in independent cohorts with prospective PSE ascertainment is required before clinical implementation.
Ischemic stroke (IS) represents a leading cause of adult mortality and long-term disability globally, and post-stroke epilepsy (PSE) constitutes a severe complication that worsens neurological recovery and reduces quality of life, yet reliable early predictive biomarkers remain insufficient. The serum lactate-to-albu...
Background/Objectives: Elevated C-reactive protein (CRP) has been associated with adverse outcomes after acute ischemic stroke (AIS), but whether the association differs by stroke etiology remains uncertain. We evaluated elevated CRP in relation to 3-month functional outcome across Trial of Org 10172 in Acute Stroke Tr...
Yoonji Oh, Jeong Ung Jeong, Sang-Hun Lee et al.· Journal of Clinical Medicine· 0 citations
Background Post-stroke seizures (PSS) are common in critically ill stroke patients, but ICU-specific risk prediction tools are lacking, and the independent impact of PSS on mortality remains controversial. Methods This retrospective multicenter cohort included 6,586 adult stroke patients from 208 US ICUs in the Collabo...
Yue Zhang, Xiao-Cui Yang, Yu Kang et al.· Frontiers in Neurology· 0 citations
Background Deep vein thrombosis (DVT) and poststroke epilepsy (PSE) are clinically important complications after acute ischemic stroke. DVT commonly occurs in patients with greater neurological impairment, immobility, inflammation, and hypercoagulability, factors that may also be associated with PSE. Whether DVT is ind...
Erxinxian Bei, Run-Zhui Lin, Le Zhao et al.· Frontiers in Neurology· 0 citations
ABSTRACT Background Post‐stroke epilepsy (PSE) is a common and serious complication of stroke, yet simple and efficient risk assessment tools remain lacking in clinical practice. This study aimed to investigate the association between multiple core inflammation‐derived indices and PSE, and to explore their potential re...
Yu Wang, Ye Gao, Long Wang· CNS Neuroscience & Therapeut...· 0 citations